# \[Medical treatment of endometriosis: comparative study of leuprolide acetate and danazol\].

> PubMed lists PMID 8065590 in Minerva ginecologica as Clinical Trial, Comparative Study, English Abstract, Journal Article, Randomized Controlled Trial, with publication-date metadata of 1994-04 (month precision). PeptideScanner associated the retained record with the identity slug leuprolide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-8065590-leuprolide:v1`
- Evidence domain: Literature metadata
- Date in source: 2013-11-21
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-8065590-leuprolide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-8065590-leuprolide-v1.json
- Content SHA-256: `6e057d1001aefe77bb194539e05651f4f2817ff880a5b62251e9b8030f7b62a9`

## Claims and source pins

### Headline

\[Medical treatment of endometriosis: comparative study of leuprolide acetate and danazol\]. ([`pubmed-observation-pmid-8065590-2013-11-21-922ce937a831`](#source-pubmed-observation-pmid-8065590-2013-11-21-922ce937a831))

### Summary

PubMed lists PMID 8065590 in Minerva ginecologica as Clinical Trial, Comparative Study, English Abstract, Journal Article, Randomized Controlled Trial, with publication-date metadata of 1994-04 (month precision). PeptideScanner associated the retained record with the identity slug leuprolide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-8065590-2013-11-21-922ce937a831`](#source-pubmed-observation-pmid-8065590-2013-11-21-922ce937a831))

### Paragraph 1

PubMed lists PMID 8065590 in Minerva ginecologica as Clinical Trial, Comparative Study, English Abstract, Journal Article, Randomized Controlled Trial, with publication-date metadata of 1994-04 (month precision). PeptideScanner associated the retained record with the identity slug leuprolide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-8065590-2013-11-21-922ce937a831`](#source-pubmed-observation-pmid-8065590-2013-11-21-922ce937a831))

### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-8065590-2013-11-21-922ce937a831`](#source-pubmed-observation-pmid-8065590-2013-11-21-922ce937a831))

## Sources

<a id="source-pubmed-observation-pmid-8065590-2013-11-21-922ce937a831"></a>
- **\[Medical treatment of endometriosis: comparative study of leuprolide acetate and danazol\]. · retained source version 1:2013-11-21:current:922ce937a83130fbba1502af2254d4fdbdf15c47a2247fed5ec80ab794e8521d** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/8065590/) (`pubmed-observation-pmid-8065590-2013-11-21-922ce937a831`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "\[Medical treatment of endometriosis: comparative study of leuprolide acetate and danazol\]." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-8065590-leuprolide-v1.json SHA-256: 6e057d1001aefe77bb194539e05651f4f2817ff880a5b62251e9b8030f7b62a9.